Tech Company Financing Transactions

XTuit Pharmaceuticals Funding Round

Polaris Partners and private investors participated in a $4 million funding round for XTuit Pharmaceuticals. This venture round was recorded on 12/31/2014.

Transaction Overview

Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
35 Gatehouse Dr. A1
Waltham, MA 02451
USA
Email Address
Overview
XTuit Pharmaceuticals, Inc. is a biopharmaceutical company developing novel microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response.
Profile
XTuit Pharmaceuticals LinkedIn Company Profile
Social Media
XTuit Pharmaceuticals Company Twitter Account
Company News
XTuit Pharmaceuticals News
Facebook
XTuit Pharmaceuticals on Facebook
YouTube
XTuit Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alan Crane
  Alan Crane LinkedIn Profile  Alan Crane Twitter Account  Alan Crane News  Alan Crane on Facebook
Chief Scientific Officer
Peter Blume-Jensen
  Peter Blume-Jensen LinkedIn Profile  Peter Blume-Jensen Twitter Account  Peter Blume-Jensen News  Peter Blume-Jensen on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2014: HDL Therapeutics venture capital transaction
Next: 12/31/2014: Cobalt Technologies venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary